CHAIR
:
SPEAKER
(S):
Ehud Shapiro, Department of Computer Science & Applied Math and Department of biological chemistry, Weizmann Institute of Science
Shimon Eckhouse, Chairman of the Board, Syneron Medical Ltd.
David Aviezer, President & CEO, Protalix Biotherapeutics Inc.
Description
Israel is currently rated first in the world for medical device patents per capita, fourth for bio-pharma patents, and among the three worldwide leading countries in the medical device arena. Israel with its largest number of scientists per capita in the world has the highest civilian R&D budget/GDP, and is fourth in investments in Biotechnology/GDP. The increasing convergence of biomedical technologies and other science driven domains such as nanotech, smart materials, new sensors and leading-edge electronics presents enormous opportunities for Israel and its global partners.
Objectives:
Examine Israeli entrepreneurship.
Find out how academic excellence and applied interdisciplinary research boosts Israel's standings.
Learn about business opportunities for Israel and its global partners